Kılıç, S. S.Çekiç, S.Karalı, Y.2024-10-022024-10-022019-08-010105-4538https://hdl.handle.net/11452/45625Bu çalışma, 01-05, Haziran 2019 tarihlerinde Lisbon[Portekiz]’de düzenlenen Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineAllergyImmunologyAllergyImmunologyCerebral ischemic attacks in ADA2 deficiency treated with adalimumabMeeting Abstract00048025400447282882874Supplement 106, Special Issue SI